CT and MRI of diffuse liver disease
- PMID: 7718279
- DOI: 10.1016/0887-2171(95)90012-8
CT and MRI of diffuse liver disease
Abstract
CT and MRI contribute important information to the clinical evaluation of diffuse liver disease. In some cases, these modalities can establish a diagnosis that was not ascertained histologically, which is often the case when sampling errors prevent a definitive tissue diagnosis. Characteristic alterations of liver attenuation on CT, signal changes on MRI, and morphological changes appreciated with both modalities can be used to diagnose fatty infiltration, some parenchymal deposition diseases, and cirrhosis. Furthermore, hepatocellular disease can be confirmed in the setting of indeterminate clinical and laboratory findings. Significant overlap in the imaging findings of this wide range of disorders continues to limit specificity; however, at a minimum, these techniques provide a rapid means to a noninvasive evaluation that often guides clinical decisions. Faster scanning techniques available with CT and MRI may provide additional information by assessing contrast dynamics. This review of CT and MRI in diffuse liver disease considers the diagnostic utility and clinical implications of these modalities. Pathological findings relevant to imaging considerations are discussed.
Similar articles
-
Imaging of diffuse liver disease.Semin Liver Dis. 2001 May;21(2):195-212. doi: 10.1055/s-2001-15496. Semin Liver Dis. 2001. PMID: 11436572 Review.
-
Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.Intervirology. 2008;51 Suppl 1:17-26. doi: 10.1159/000122595. Epub 2008 Jun 10. Intervirology. 2008. PMID: 18544944
-
The contribution of percutaneous liver biopsy to the management of liver disease.Med J Aust. 1973 Jul 28;2(4):160-3. doi: 10.5694/j.1326-5377.1973.tb128749.x. Med J Aust. 1973. PMID: 4741341 No abstract available.
-
Diffuse disease of the liver: radiologic-pathologic correlation.Radiographics. 1994 Nov;14(6):1291-307. doi: 10.1148/radiographics.14.6.7855342. Radiographics. 1994. PMID: 7855342
-
Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques.J Gastroenterol Hepatol. 2012 Aug;27(8):1281-92. doi: 10.1111/j.1440-1746.2012.07127.x. J Gastroenterol Hepatol. 2012. PMID: 22432836 Review.
Cited by
-
Non-alcoholic fatty liver disease: The diagnosis and management.World J Hepatol. 2015 Apr 28;7(6):846-58. doi: 10.4254/wjh.v7.i6.846. World J Hepatol. 2015. PMID: 25937862 Free PMC article. Review.
-
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Cochrane Database Syst Rev. 2013 Dec 27;2013(12):CD008623. doi: 10.1002/14651858.CD008623.pub2. Cochrane Database Syst Rev. 2013. PMID: 24374462 Free PMC article.
-
Therapy for alcoholic liver disease.World J Gastroenterol. 2014 Mar 7;20(9):2143-58. doi: 10.3748/wjg.v20.i9.2143. World J Gastroenterol. 2014. PMID: 24605013 Free PMC article. Review.
-
Herpes Simplex Virus Type 2 Hepatitis: An Uncommon Cause of Persistent Fever in a Late Post-Transplant Liver Recipient.Am J Case Rep. 2024 Dec 2;25:e945140. doi: 10.12659/AJCR.945140. Am J Case Rep. 2024. PMID: 39618065 Free PMC article.
-
Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).Sao Paulo Med J. 2015 Mar-Apr;133(2):115-24. doi: 10.1590/1516-3180.2014.9150812. Epub 2015 Apr 1. Sao Paulo Med J. 2015. PMID: 26018881 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical